Literature DB >> 4066918

Intravenous catheter-associated fungemia due to Candida rugosa.

J F Reinhardt, P J Ruane, L J Walker, W L George.   

Abstract

We report a case of intravenous catheter-associated fungemia caused by Candida rugosa; this is the first report of such an infection in a human. Multiple cultures of blood taken over a 24-h period and of the intravenous catheter tip were positive for this unusual isolate. The patient was treated with intravenous amphotericin B and made an uneventful recovery. Intravenous cannulae and other intravascular devices are well recognized as potential sites of intravascular infection by a variety of microorganisms, including several Candida species; however, fungemia caused by C. rugosa has not been reported.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4066918      PMCID: PMC271880          DOI: 10.1128/jcm.22.6.1056-1057.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  [Dermatomycoses in miners of the "Anna" mine].

Authors:  K H Bründel
Journal:  Berufsdermatosen       Date:  1977-10

2.  Venous catheter-associated candidemia.

Authors:  H D Rose
Journal:  Am J Med Sci       Date:  1978 May-Jun       Impact factor: 2.378

3.  [Esophageal mycoses].

Authors:  B Moulinier; R Lambert; P Grenier-Boley; J Bruhière
Journal:  Nouv Presse Med       Date:  1972-11-04

4.  Detection of yeasts and filamentous fungi in blood cultures during a 10-year period (1972 to 1981).

Authors:  J Bille; L Stockman; G D Roberts
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

5.  A semiquantitative culture method for identifying intravenous-catheter-related infection.

Authors:  D G Maki; C E Weise; H W Sarafin
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

6.  Detection of yeast septicemia by biphasic and radiometric methods.

Authors:  E Prevost; E Bannister
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

7.  Identification of yeasts from infected bovine mammary glands and their experimental infectivity in cattle.

Authors:  J L Richard; J S McDonald; R E Fichtner; A J Anderson
Journal:  Am J Vet Res       Date:  1980-12       Impact factor: 1.156

8.  Radiometric detection of yeasts in blood cultures of cancer patients.

Authors:  R L Hopfer; A Orengo; S Chesnut; M Wenglar
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

9.  In vitro antimycotic sensitivity of yeasts isolated from infected bovine mammary glands.

Authors:  J S McDonald; J L Richard; A J Anderson; R E Fichtner
Journal:  Am J Vet Res       Date:  1980-12       Impact factor: 1.156

10.  Comparative recovery of fungi from biphasic and conventional blood culture media.

Authors:  T E Kiehn; C Capitolo; J B Mayo; D Armstrong
Journal:  J Clin Microbiol       Date:  1981-12       Impact factor: 5.948

  10 in total
  10 in total

Review 1.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

2.  Torulopsis candida, a new opportunistic pathogen.

Authors:  G St-Germain; M Laverdière
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

3.  Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.

Authors:  M A Pfaller; D J Diekema; A L Colombo; C Kibbler; K P Ng; D L Gibbs; V A Newell
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

4.  DNA fingerprinting of Candida rugosa via repetitive sequence-based PCR.

Authors:  R J Redkar; M P Dubé; F K McCleskey; M G Rinaldi; V G Del Vecchio
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

Review 5.  New and emerging yeast pathogens.

Authors:  K C Hazen
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.

Authors:  J M Hernández Molina; J Llosá; A Martinez Brocal; A Ventosa
Journal:  Mycopathologia       Date:  1992-04       Impact factor: 2.574

7.  Catheter-associated Candida utilis fungemia in a patient with acquired immunodeficiency syndrome: species verification with a molecular probe.

Authors:  A Alsina; M Mason; R A Uphoff; W S Riggsby; J M Becker; D Murphy
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

8.  Resolutive Candida utilis fungemia in a nonneutropenic patient.

Authors:  M E Bougnoux; E Gueho; A C Potocka
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

9.  Evaluation of pulsed-field gel electrophoresis as a typing system for Candida rugosa: comparison of karyotype and restriction fragment length polymorphisms.

Authors:  J C Dib; M Dube; C Kelly; M G Rinaldi; J E Patterson
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

10.  Treatment of invasive candidiasis in the elderly: a review.

Authors:  Aikaterini Flevari; Maria Theodorakopoulou; Aristea Velegraki; Apostolos Armaganidis; George Dimopoulos
Journal:  Clin Interv Aging       Date:  2013-09-09       Impact factor: 4.458

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.